This month I have no trade to report, because I am happy with the portfolio’s shape, and, as you will notice if you read the Share Watch column (see page 76), my quest to find new investments that might be better than those I have already picked has drawn a blank.
It’s the Nifty Thrifty portfolio’s eighth anniversary and I’m afraid the news this time is no better than the news last June. The portfolio has edged up in value by 3 per cent over the intervening year, to just over £56,500, but the benchmark FTSE 350 index-tracking fund has increased in value by 6 per cent to just under £60,000. It looks as though the index-tracking fund, an almost effortless investment that required just one decision in June 2010, will be the first to double its original £30,000 stake.
Each month Richard Beddard trawls through annual corporate results for his Watchlist and the Share Sleuth portfolio of companies that satisfy key valuation metrics such as earnings yield and return on capital – and profiles the most interesting candidates.
Judges Scientific (JDG): set to profit despite stop-go
In comparison to 2016, the year to December 2017 was a good year for Judges Scientific. The scientific instrument manufacturer increased revenue 25 per cent and profit by more than 50 per cent.
Probably the most influential book I have ever read about investing was One Up on Wall Street, first published in 1988. The author was Peter Lynch, who achieved fame and fortune managing the Fidelity Magellan fund in the 1980s. Lynch worked for one of America’s pre-eminent fund management companies. He was a pro through and through, but he was also an enthusiast, a stockpicker who loved nothing more than to figure out companies.
There are challenges ahead, but Richard Beddard thinks Judges Scientific should prosper over the long term.
Why I have decided against adding to the holding in building materials manufacturer Alumasc, despite its profitability.
Richard Beddard thinks customers of his favourite share may have gorged themselves and as a result profits could stall.
Richard Beddard reports on his decision to buy more shares in defence technology company Cohort for the first time in five years.
Richard Beddard identifies a shortlist of resilient, adaptable, profitable and fairly run firms whose shares are relatively inexpensive.
The portfolio needs some rebalancing, having been bent out of shape by the roaring bull market.